Sector: MedicalDORB (OTCBB: DORB)
Ranking History
Scan Date: | 2/2/2010 |
Sector: | Medical |
Funamental : | 262 |
Technical : | 233 |
Performance : | 89 |
Overall: | 232 |
Number of Stocks: | 309 |
Scan Date: | 1/26/2010 |
Sector: | Medical |
Funamental : | 261 |
Technical : | 247 |
Performance : | 91 |
Overall: | 240 |
Number of Stocks: | 309 |
Scan Date: | 1/19/2010 |
Sector: | Medical |
Funamental : | 260 |
Technical : | 248 |
Performance : | 92 |
Overall: | 245 |
Number of Stocks: | 308 |
Headlines
- /C O R R E C T I O N -- Soligenix, Inc./
Sep 30, 2009 09:41 AM | DORB
- DOR BioPharma Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol 'SGNX'
Sep 30, 2009 07:01 AM | DORB
- DOR BioPharma Announces Private Equity Financing of $3.85 Million with its Partner Sigma-Tau and Other Institutional Investors
Sep 24, 2009 09:41 AM | DORB
- DOR BioPharma Announces $9.4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines
Sep 21, 2009 07:01 AM | DORB
- DOR BioPharma Announces NIH Grant Award to Support Phase 1/2 Clinical Trial of DOR201 in Radiation Enteritis
Sep 08, 2009 07:00 AM | DORB
- DOR BioPharma to Present at the Rodman & Renshaw Annual Global Investor Healthcare Conference
Sep 03, 2009 08:01 AM | DORB
- OTC Select Announces Daily Stock Watch - ADXS, CYNX, DORB, ELRA, EMIS
Jun 10, 2009 09:01 AM | DORB, EMIS
- GeneThera in Talks With Nasdaq Company About Merger and U.S. Court of Appeals Supports Hemispherx in Rebuff of Hostile Takeover Attempt
Jan 05, 2009 11:30 AM | DORB, HEB, IDIX
- DOR BioPharma Reports 2nd Quarter and 1st Half 2009 Financial Results and Reviews Recent Accomplishments
Aug 14, 2009 08:01 AM | DORB
- DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD
Aug 04, 2009 07:01 AM | DORB
- DOR BioPharma Announces Issuance of European Patent for its LPM(TM) Oral Drug Delivery Technology
Jul 08, 2009 08:01 AM | DORB
- DOR BioPharma Appoints Christopher P. Schnittker, CPA, as Vice President of Administration and Controller
Jul 07, 2009 08:02 AM | DORB
- DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD
Jun 09, 2009 07:01 AM | DORB
- DOR BioPharma Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments
May 15, 2009 08:01 AM | DORB
- Life Science Leaders to Discuss Finding Investors in a Tough Economy
May 07, 2009 11:02 AM | DORB
- DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments
Mar 31, 2009 08:04 AM | DORB
- DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation
Mar 25, 2009 07:02 AM | DORB
- DOR BioPharma Appoints Gregg Lapointe, CPA, MBA, to its Board of Directors
Mar 16, 2009 07:15 AM | DORB
- Form 4 SIGMA TAU FINANZIARIA For: Sep 24 (10K)
Sep 28, 2009 03:01 PM
- Form 4 CAVAZZA PAOLO For: Sep 24 (10K)
Sep 28, 2009 03:01 PM
- Form 4 CAVAZZA CLAUDIO For: Sep 24 (10K)
Sep 28, 2009 02:59 PM
- Form 4 SCHNITTKER CHRISTOPHER For: Jul 01 (10K)
Jul 09, 2009 06:48 PM
- Form 4 Buhrman Cyrille F For: Jun 04 (10K)
Jul 09, 2009 06:29 PM
- Form 4 Brey Robert N For: Mar 27 (10K)
Mar 30, 2009 05:31 PM
- Form 3 Brey Robert N For: Mar 27 (10K)
Mar 30, 2009 05:27 PM
- Form 4 Lapointe Gregg Anthony For: Mar 10 (10K)
Mar 16, 2009 07:47 PM
- Form 3 Lapointe Gregg Anthony For: Mar 10 (10K)
Mar 16, 2009 07:24 PM
- Form 3 Hamilton Brian L For: Mar 11 (10K)
Mar 16, 2009 06:19 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
DORB
|
Compare to S&P
|
| YTD |
308.33 %
|
253.15 %
|
| 4 Weeks |
19.51 %
|
17.74 %
|
| 12 Weeks |
36.11 %
|
16.83 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 0.00 %
|
|
EPS Growth in Last Year: 0.00 %
|
|
Sales Growth in Last Quarter: -40.00 %
|
|
Sales Growth in Last Quarter: -38.52 %
|
|
